China SXT Pharmaceuticals, Inc. (SXTC) Stock Analysis & Investment Frameworks

China SXT Pharmaceuticals, Inc. (SXTC) stock analysis on Invetso. Review China SXT Pharmaceuticals, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

China SXT Pharmaceuticals, Inc. Company Overview

China SXT Pharmaceuticals, Inc. Key Financial Metrics

About China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

China SXT Pharmaceuticals, Inc. Investment Frameworks

Invetso analyzes China SXT Pharmaceuticals, Inc. (SXTC) across the following frameworks:

Explore More SXTC Research